References

Prevention and treatment of acute GvHD

10.1038/bmt.2008.57 · 2008 · External reference

Adenosine A(2)A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease

10.4049/jimmunol.1201325 · 2013 · External reference

Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation

10.1189/jlb.0609388 · 2010 · External reference

Acute graft versus host disease

10.1186/1750-1172-2-35 · 2007 · External reference

10.1155/2011/601953

10.1155/2011/601953 · External reference

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

2014 · External reference

The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine–A2A adenosine receptor pathway

10.3389/fimmu.2012.00190 · 2012 · External reference

Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia

10.1016/j.brainres.2014.01.014 · 2014 · External reference

Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis

10.4049/jimmunol.177.5.2765 · 2006 · External reference

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson

10.1182/blood-2012-11-465963 · 2013 · External reference

Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice

10.1111/exd.12461 · 2014 · External reference

10.1111/j.1365-2141.2012.09129.x

10.1111/j.1365-2141.2012.09129.x · External reference

Pathophysiologic mechanisms of acute graft-vs.-host disease

10.1016/s1083-8791(99)70011-x · 1999 · External reference

Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation

2008 · External reference

10.1016/j.cell.2008.05.009

10.1016/j.cell.2008.05.009 · External reference

10.1093/intimm/dxp095

10.1093/intimm/dxp095 · External reference

10.1084/jem.156.6.1577

10.1084/jem.156.6.1577 · External reference

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

10.1084/jem.161.1.72 · 1985 · External reference

10.4049/jimmunol.0804308

10.4049/jimmunol.0804308 · External reference

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

10.1016/s1074-7613(02)00367-9 · 2002 · External reference

10.1172/jci11679

10.1172/jci11679 · External reference

10.1038/83707

10.1038/83707 · External reference

10.1038/83713

10.1038/83713 · External reference

Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells

10.1016/s0006-2952(00)00570-0 · 2001 · External reference

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors

10.1016/s0031-6997(24)01511-4 · 2001 · External reference

10.1038/414916a

10.1038/414916a · External reference

10.4049/jimmunol.177.10.6780

10.4049/jimmunol.177.10.6780 · External reference

10.1084/jem.20062512

10.1084/jem.20062512 · External reference

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

10.1182/blood-2007-03-081646 · 2008 · External reference

Turnover of adenosine in plasma of human and dog blood

10.1152/ajpcell.1989.256.4.c799 · 1989 · External reference

10.3389/fimmu.2014.00304

10.3389/fimmu.2014.00304 · External reference

A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis

10.1086/386311 · 2004 · External reference

10.1084/jem.20061097

10.1084/jem.20061097 · External reference

10.1186/ar1914

10.1186/ar1914 · External reference

10.1038/nrd3955

10.1038/nrd3955 · External reference

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy

10.1152/ajprenal.00310.2005 · 2006 · External reference

Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation

10.1097/01.tp.0000260140.04815.77 · 2007 · External reference

10.1002/eji.200636123

10.1002/eji.200636123 · External reference

Ex vivo-expanded CD4+ CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells

10.4049/jimmunol.176.2.1266 · 2006 · External reference

10.1016/j.bbmt.2007.01.071

10.1016/j.bbmt.2007.01.071 · External reference

Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes

10.4049/jimmunol.146.7.2108 · 1991 · External reference

Critical role of interleukin-2 in the development of acute graft-versus-host disease

10.1093/intimm/5.6.565 · 1993 · External reference

Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease

10.4049/jimmunol.139.6.1840 · 1987 · External reference

10.1038/35085068

10.1038/35085068 · External reference

10.1007/s00109-010-0642-1

10.1007/s00109-010-0642-1 · External reference

10.1002/eji.200838105

10.1002/eji.200838105 · External reference

10.1084/jem.20070109

10.1084/jem.20070109 · External reference

10.1016/j.immuni.2009.10.006

10.1016/j.immuni.2009.10.006 · External reference

The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells

10.1189/jlb.72.5.1027 · 2002 · External reference

An Fc domain protein-small molecule conjugate as an enhanced immunomodulator

10.1021/ja5006674 · 2014 · External reference